Truehand Inc’s Bristol-Myers Squibb BMY Stock Holding History

Truehand Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.07M	Sell	33,190 -3,000	-8%	-$176K	1.21%	31
2021 Q3	$2.14M	Hold	36,190	–	–	1.27%	31
2021 Q2	$2.42M	Hold	36,190	–	–	1.42%	27
2021 Q1	$2.29M	Hold	36,190	–	–	1.4%	27
2020 Q4	$2.25M	Hold	36,190	–	–	1.48%	25
2020 Q3	$2.18M	Sell	36,190 -133	-0.4%	-$8.01K	1.57%	22
2020 Q2	$2.13M	Sell	36,323 -1,401	-4%	-$83.8K	1.65%	19
2020 Q1	$2.1M	Hold	37,724	–	–	1.98%	14
2019 Q4	$2.42M	Sell	37,724 -1,400	-4%	-$80.2K	1.84%	21
2019 Q3	$1.98M	Hold	39,124	–	–	1.54%	25
2019 Q2	$1.77M	Sell	39,124 -35	-0.1%	-$1.63K	1.35%	32
2019 Q1	$1.87M	Hold	39,159	–	–	1.42%	28
2018 Q4	$2.04M	Buy	+39,159	New	+$2.1M	1.73%	21

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Truehand Inc's BMY Position: Q4 2021 in Review

Truehand Inc reduced its Bristol-Myers Squibb (BMY) stake by 8.3% in Q4 2021, selling an estimated $176K and leaving 33,190 shares worth $2.07M. The position accounts for 1.21% of the portfolio, ranked #31.

Truehand Inc first reported a position in BMY in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.42M in Q4 2019. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Truehand Inc held 33,190 shares of Bristol-Myers Squibb worth $2.07M as of Q4 2021.
Truehand Inc sold 3,000 Bristol-Myers Squibb shares in Q4 2021, an estimated $176K.
Bristol-Myers Squibb made up 1.21% of Truehand Inc's portfolio in Q4 2021, its #31 holding.
Truehand Inc first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 13 quarters since.
Truehand Inc's Bristol-Myers Squibb position peaked at $2.42M in Q4 2019.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Truehand Inc's 13F filing for Q4 2021, filed 9 Feb 2022.